Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Fichera

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
World Journal of Gastroenterology|September 30, 2021
Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the futureChiara Viganò, Giacomo Mulinacci, Andrea Palermo, et al.
Expert Review of Clinical Immunology|February 1, 2023
The oft-overlooked cardiovascular complications of inflammatory bowel diseaseSara Massironi, Giacomo Mulinacci, Camilla Gallo, et al.
World Journal of Gastrointestinal Surgery|August 6, 2021
Acute mesenteric ischemia and small bowel imaging findings in COVID-19: A comprehensive review of the literatureLorena Pirola, Andrea Palermo, Giacomo Mulinacci, et al.
Alimentary Pharmacology & Therapeutics|May 4, 2022
Systematic review-pancreatic involvement in inflammatory bowel diseaseSara Massironi, Ilaria Fanetti, Chiara Viganò, et al.
Journal of Crohn'S & Colitis|November 26, 2013
ABO histo-blood group might modulate predisposition to Crohn's disease and affect disease behaviorDiego Forni, Isabelle Cleynen, Marc Ferrante, et al.
Journal of Clinical Gastroenterology|February 3, 2018
Virtual Chromoendoscopy With FICE for the Classification of Polypoid and Nonpolypoid Raised Lesions in Ulcerative ColitisAndrea Cassinotti, Federico Buffoli, Paolo Fociani, et al.
Molecular Biology and Evolution|February 8, 2013
Crohn's disease loci are common targets of protozoa-driven selectionRachele Cagliani, Uberto Pozzoli, Diego Forni, et al.
The New England Journal of Medicine|March 19, 2015
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's diseaseGiovanni Monteleone, Markus F Neurath, Sandro Ardizzone, et al.
European Journal of Gastroenterology & Hepatology|September 27, 2022
Continuous clinical remission with biologics in ulcerative colitis: the 'AURORA' comparison studyAndrea Cassinotti, Nicolò Mezzina, Annalisa De Silvestri, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
World Journal of Gastroenterology|September 30, 2021
Impact of COVID-19 on inflammatory bowel disease practice and perspectives for the futureChiara Viganò, Giacomo Mulinacci, Andrea Palermo, et al.
Expert Review of Clinical Immunology|February 1, 2023
The oft-overlooked cardiovascular complications of inflammatory bowel diseaseSara Massironi, Giacomo Mulinacci, Camilla Gallo, et al.
World Journal of Gastrointestinal Surgery|August 6, 2021
Acute mesenteric ischemia and small bowel imaging findings in COVID-19: A comprehensive review of the literatureLorena Pirola, Andrea Palermo, Giacomo Mulinacci, et al.
Alimentary Pharmacology & Therapeutics|May 4, 2022
Systematic review-pancreatic involvement in inflammatory bowel diseaseSara Massironi, Ilaria Fanetti, Chiara Viganò, et al.
Journal of Crohn'S & Colitis|November 26, 2013
ABO histo-blood group might modulate predisposition to Crohn's disease and affect disease behaviorDiego Forni, Isabelle Cleynen, Marc Ferrante, et al.
Journal of Clinical Gastroenterology|February 3, 2018
Virtual Chromoendoscopy With FICE for the Classification of Polypoid and Nonpolypoid Raised Lesions in Ulcerative ColitisAndrea Cassinotti, Federico Buffoli, Paolo Fociani, et al.
Molecular Biology and Evolution|February 8, 2013
Crohn's disease loci are common targets of protozoa-driven selectionRachele Cagliani, Uberto Pozzoli, Diego Forni, et al.
The New England Journal of Medicine|March 19, 2015
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's diseaseGiovanni Monteleone, Markus F Neurath, Sandro Ardizzone, et al.
European Journal of Gastroenterology & Hepatology|September 27, 2022
Continuous clinical remission with biologics in ulcerative colitis: the 'AURORA' comparison studyAndrea Cassinotti, Nicolò Mezzina, Annalisa De Silvestri, et al.
Pageof 1